Billionaire Profile
Clemens Fischer
Global Rank
#3082

Image: Public domain | via Wikimedia Commons

Clemens Fischer

CEO, Futrue GmbH
DE
Real-Time Net Worth
$0.4B
As of December 2025
Age
50
Source
Pharmaceuticals
Industry
diversified
Citizenship
DE

Biography

Dr. Clemens Fischer is a German entrepreneur and investor, best known for founding Futrue, a healthcare group with over 20 companies. Born on May 28, 1975, he holds a doctorate in medicine, a master's in business economics, and an MBA from Harvard Business School. His career includes leadership roles at Novartis and a successful track record of selling companies for millions. Fischer's current focus is on expanding Futrue, developing innovative pain therapies, and driving scientific advancements through Futrue Research & Science. His entrepreneurial journey began early, and he was awarded "CEO of the Future" in 2007.

Wealth Over Time

In-Depth Profile

Early Life and Education

Clemens Fischer was born on May 28, 1975, in Germany. Fischer's journey began with an early entrepreneurial spirit, launching a stamp-selling business at age eight. At 17, he owned a mobile phone company, showcasing his serial entrepreneurship. He received a strong education, culminating in a medical degree, a doctorate, a master's in Economics and Business Administration, and an MBA from Harvard Business School, laying a solid foundation for his future ventures.

Rise to Success

Fischer's career includes experience at Novartis, where he held a position on the German executive board, overseeing strategy and cardiovascular divisions. His entrepreneurial career took off with the founding of Futrue, an international healthcare group. He has a knack for identifying market opportunities, as evidenced by his development of the diet product Yokebe, which he sold to Perrigo for approximately 150 million euros. He founded PharmaSGP in 2009 and remains Chairman-Supervisory Board.

Key Business Strategies

A key strategy for Fischer has been to build and then sell companies after successful market positioning. He has shown an ability to quickly bring innovative ideas to market. Futrue's focus is on the healthcare sector with ventures in areas such as intelligent bacteria, pain therapies, medical cannabis, and e-health. He is also focused on creating disruptive innovative therapies through Futrue Research & Science. He has set the ambitious goal of halving the development time of new therapies.

Philanthropy

Information on specific philanthropy amounts for Clemens Fischer is not available.

Career Milestones

2007

CEO of the Future Award

Awarded by McKinsey and Manager Magazin.

2008

Founded Futrue GmbH

An international healthcare incubator with over 20 companies.

2009

Founded PharmaSGP GmbH

Focuses on chemical-free drugs.

2011

Developed Kijimea Reizdarm Pro

Brought the first probiotic medical product for the treatment of irritable bowel syndrome to market.

2020

PharmaSGP went public.

Clemens Fischer's company.

2024

Application for VER-01

The application for the approval of VER-01 was submitted.